Science 37 Quote - SNCE

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

5.75

Bid

5.72

Ask

5.74

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

5.75

Open

Last Trade

Last Trade Time

Average Volume (3m)

Financial Volume

VWAP

Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation

MORRISVILLE, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, announces the appointment of Tyler Van Horn as Chief Executive Officer...

Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial

MORRISVILLE, N.C., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, was a key enrolling site for the primary completion of a Phase 3 rare...

Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical Trials

MORRISVILLE, N.C., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Today, Science 37, a leader in enhancing patient access to clinical trials, announced that it has received Frost & Sullivan’s 2024...

Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC

MORRISVILLE, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, today announced the grand opening of its new, 19,000-square-foot...

Science 37 Enrolls 42% of Trial Cohort in 8 Weeks

MORRISVILLE, N.C., July 18, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, disclosed the final figures resulting from its partnership with a...

Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials

RESEARCH TRIANGLE PARK, N.C., June 27, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, has been added to over 20 studies that were lagging in...

CORRECTION-- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial

RESEARCH TRIANGLE PARK, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Science 37, Inc., please note that the first sentence of the second...

Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial

RESEARCH TRIANGLE PARK, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc., a leader in enhancing patient access to clinical trials, announced the final enrollment figures from...

Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance

RESEARCH TRIANGLE PARK, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. today announced the preliminary outcome of its recent FDA Inspection focusing on critical areas and...

Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”

Science 37’s Patient Recruitment Recognized in Prestigious International Annual Awards Program for Standout Digital Health & Medical Technology Products and Companies RESEARCH TRIANGLE PARK...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

SNCE - Frequently Asked Questions (FAQ)

What is the current Science 37 share price?

The current share price of Science 37 is US$ 5.75

What is the 1 year trading range for Science 37 share price?

Science 37 has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VSTEVast Renewable Ltd	US$ 1.17 (69.57%)	11.77M
OCEAOcean Biomedical Inc	US$ 0.238 (60.81%)	40.75M
NOEMCO2 Energy Transition Corporation	US$ 15.76 (59.68%)	4
BBGIBeasley Broadcast Group Inc	US$ 12.48 (59.18%)	4
BSBKBogota Financial Corporation	US$ 12.29 (55.18%)	9
AIRJAirJoule Technologies Corporation	US$ 5.21 (-41.00%)	1
PRAAPRA Group Inc	US$ 14.01 (-39.69%)	7
CFSBCFSB Bancorp Inc	US$ 5.00 (-36.06%)	223
FLNCFluence Energy Inc	US$ 8.40 (-35.73%)	260.29k
SLNGStabilis Solutions Inc	US$ 5.12 (-33.16%)	5
CYNCYNGN Inc	US$ 0.2851 (54.36%)	102.28M
OCEAOcean Biomedical Inc	US$ 0.238 (60.81%)	40.77M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0898 (30.14%)	22.98M
CLEUChina Liberal Education Holdings Ltd	US$ 0.1406 (29.59%)	20.47M
VSTEVast Renewable Ltd	US$ 1.17 (69.57%)	11.77M